Hypothesis: Telomere length reflects chromatin entropy rather than mitotic count in human endometrial stromal cells

Core proposition If telomeres act as a quantum clock measuring informational entropy, then their length should correlate with epigenetic disorder (e.g., loss of H3K9me3, increased DNA methylation variance) independent of the number of cell divisions. In the endometrium, where stromal cells shed and regenerate every ~28 days, this predicts that senescent endometrial stromal cells (EnSCs) will show shortened telomeres despite low proliferative indices, and that rescuing chromatin organization will normalize telomere length without altering division rate.

Mechanistic extension CDC42 deficiency triggers Wnt/β‑catenin hyperactivity, which remodels nucleosome positioning and reduces heterochromatin protein 1α (HP1α) binding at subtelomeric regions. Loss of HP1α increases telomeric nucleosome breathing, exposing telomeric DNA to oxidative damage and facilitating telomere‑associated RNA (TERRA) transcription, thereby accelerating telomere shortening. Crucially, this process does not require S‑phase passage; it can occur during G0/G1 when EnSCs are quiescent between cycles.

Testable predictions

1. Correlation: In matched proliferative (Ki67⁺) and secretory (Ki67⁻) EnSCs from the same menstrual cycle, telomere length (measured by Flow‑FISH or scTelo‑seq) will be negatively correlated with entropy scores derived from single‑cell ATAC‑seq or scRRBS methylation variance, but not with Ki67 intensity.
2. Intervention: Pharmacologic inhibition of Wnt (e.g., IWP‑2) or forced expression of a CDC42‑resistant β‑catenin mutant in CDC42‑deficient EnSCs will restore HP1α telomeric binding, reduce methylation entropy, and lengthen telomeres without changing proliferation rates (EdU incorporation).
3. Falsifiability: If telomere shortening strictly mirrors division count, then inhibiting Wnt or restoring CDC42 will not affect telomere length despite rescuing senescence markers; conversely, if entropy drives telomere loss, telomere length will improve even when division history is unchanged.

Experimental design

• Obtain endometrial biopsies from women with recurrent implantation failure (CDC42‑low) and fertile controls across proliferative and secretory phases.
• Perform single‑cell multi‑omics: scRNA‑seq (to confirm CDC42/Wnt signatures), scTelo‑seq (telomere length), scATAC‑seq (chromatin accessibility), and scRRBS (methylation entropy).
• Compute an epigenetic entropy metric: Shannon diversity of methylation states at CpG sites within 50 kb of telomeres plus ATAC‑seq nucleosome occupancy variance.
• Stratify cells by Ki67 and compare telomere length versus entropy using linear mixed models controlling for donor ID.
• In parallel, culture primary EnSCs, knock down CDC42 with siRNA, treat with IWP‑2 or overexpress β‑catenin S33Y, assay HP1α ChIP‑qPCR at telomeres, TERRA RNA‑FISH, telomere length (qPCR Flow‑FISH), and senescence (SA‑β‑gal, p16). Proliferation measured by EdU incorporation.

Expected outcome A significant negative slope between telomere length and entropy (p < 0.01) that persists after adjusting for Ki67, and rescue of telomere length by Wnt inhibition without alteration of EdU incorporation, would support the quantum‑clock view. Lack of such correlation or rescue would falsify the hypothesis, indicating that telomere attrition in EnSCs is primarily replicative.

Broader implication Confirming that telomeres read epigenetic entropy would reframe aging in regenerative tissues as a thermodynamic cost of maintaining chromatin fidelity, opening avenues to delay senescence by stabilizing telomere‑adjacent heterochromatin rather than boosting telomerase.

1 2 3